Cardiac side effects of RNA-based SARS-CoV-2 vaccines"Our present data suggest that the risk–benefit ratio of mRNA-based vaccines should be re-evaluated taking into consideration of current preclinical cardiac safety data"Mathew AldredNov 07, 2023∙ Paid122ShareThis post is for paid subscribersAlready a paid subscriber? Sign in